Pembrolizumab,Trastuzumab,Zolbetuximab,Nivolumab,Ipilimumab,Tislelizumab,oxaliplatin,capecitabine
Merck,Roche,astellas,BMS,Beigene
[]
surprised not to see much comment on $bgne $nvs rationale-305 trial of tislelizumab+chemo in 1l gastric/gej adeno. positive for mpfs &amp; mos, but seemingly only in pd-l1 expressers. more data on itt hopefully at #gi23 4:15pm pt 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.